Catalyst Biosciences, Inc.

611 Gateway Blvd.
Suite 710
South San Francisco
United States

Tel: 650-871-0761


Show jobs for this employer

About Catalyst Biosciences, Inc.

We are a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hemostasis and complement-mediated disorders. Our protease engineering platform includes two late-stage clinical programs in hemophilia; a research program on engineering of subcutaneous (SQ) complement inhibitors; and a partnered preclinical development program with Biogen for dry age-related macular degeneration (“AMD”). The product candidates generated by our protease engineering platform have improved functionality and potency that allow for: SQ administration of recombinant coagulation factors and complement inhibitors; low-dose, high activity gene therapy constructs; and less frequently dosed intravitreal therapeutics.

Catalyst Core Values

162 articles with Catalyst Biosciences, Inc.